#

Small caps

: 1220
If the drug is approved by the FDA, Compass plans to begin sales in the first half of 2027 / Photo: Compass / LinkedIn
Small Caps·
Compass could be first to U.S. market with psychedelics therapy for depression
The revision reflects concerns over the potential dilution of Birkenstock’s premium brand status amid changing consumer purchasing behavior in key markets / Photo: Facebook / Birkenstock
Small Caps·
Williams Trading downgrades Birkenstock as brand 'may be losing premium positioning'
Investment in quantum technology start-ups reached $12.6 billion in 2025, 6.3 times higher than in 2024, according to McKinsey / Photo: Germanru / Shutterstock.com
Small Caps·
Quantum small caps lost most of their 1H gains in July. Is the rally over?
Green Thumb continues generating profits while many rivals struggle, a Motley Fool analyst argues / Photo: Instagram / gtigrows
Small Caps·
Motley Fool calls Green Thumb the safest pot stock now, citing strong fundamentals
An FDA advisory panel voted that results from the study of Replimune’s experimental melanoma treatment are clinically meaningful / Photo: Replimune
Small Caps·
Biotech Replimune more than doubles after FDA panel OKs skin cancer treatment
A Cathie Wood ETF has invested in Scribe, a clinical-stage developer of gene therapies for heart diseases / Photo: Facebook / ARK Invest
Small Caps·
Small caps last week: Cathie Wood’s Scribe bet, deals to acquire Forte Bio and CBIZ
The record cybersecurity and IT modernization government contract is expected to add more than $5 million in annual recurring revenue for Cycurion / Photo: Cycurion
Small Caps·
IT small cap Cycurion soars 500% after landing biggest contract in its history
Apnimed raised $192 million in an upsized U.S. IPO, priced at the top of a marketed range / Photo: LinkedIn / Apnimed
Small Caps·
+1
·
Apnimed IPO: Sleep apnea drug developer debuts on the Nasdaq
Arras explored Besshoky, a prospective mining site in Kazakhstan, with Teck Resources / Photo: X / Arras Minerals
Small Caps·
Analysts like Canadian miner Arras for low-cost Kazakhstan copper and gold potential
CBIZ agreed to be taken private by Grant Thornton in a more than $3 billion cash deal / Photo: Facebook / cbizservices
Small Caps·
Prof. services adviser CBIZ to be acquired by peer in largest such deal in 25 years
Shares of the micro cap slumped on the share sale / Photo: Unsplash / Hans Reniers
Small Caps·
Micro-cap biotech Processa acquires immune-focused Vidya, announces share sale
Noble Capital Markets argues Beasley is building a more resilient local media platform / Facebook / BeasleyMedia
Small Caps·
Noble is first on Wall St. to cover Beasley Broadcast Group, seeing almost 50% upside
Load more